Protai

Protai is an AI-powered drug discovery startup that combines structural and functional proteomics with machine learning to map disease progression at the protein level.

Headquarters

Tel Aviv, Israel

Year Founded

2021

Founders

Dr. David Cohen

Country

Israel

Financial Information

Funding Stage

Seed

Recent Funding

$12M

Funding By

aMoon

Core Technology

Proteomics + ML

Product Type

Drug

Pipeline Stage (Very Important)

Preclinical

Regulatory Status

IND Filed: No
FDA/EMA Status: N/A
Clinical Trial Registration: N/A
Patents / IP Status: Filed

Partnerships

Pharma Collaborations

Teva

Academic / Hospital Tie-ups

Tel Aviv University

CRO/CDMO Partnerships

None

Market & Differentiation

Proteomics ML